Given that TAM suppresses CD8+ T-cell proliferation and activation, thereby facilitating HCC progression [14, 15], we hypothesized that SENP3-mediated immunosuppression in HCC may act through TAM. This evidence concerns the gene CD8A and hepatocellular carcinoma.